Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2010
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069340 Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
03/18/2010US20100069330 Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation Inhibitors
03/18/2010US20100069326 Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
03/18/2010US20100069313 Novel powders based on vegetation water from olive oil production
03/18/2010US20100069309 Method for medical treatment utilizing glutathione
03/18/2010US20100068304 Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
03/18/2010US20100068301 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
03/18/2010US20100068238 Implantable Medical Devices Comprising a Flavonoid or Derivative Thereof for Prevention of Restenosis
03/18/2010US20100068221 Low salt food with improved taste
03/18/2010US20100068200 Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation
03/18/2010US20100068199 Pcsk9 antagonists
03/18/2010US20100068190 Mesoangioblast-like cell as well as methods and uses relating thereto
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068170 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
03/18/2010US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential
03/18/2010CA2736522A1 Aza-benzimidazolone chymase inhibitors
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2734189A1 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof
03/18/2010CA2731113A1 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163548A1 Prophylactic or therapeutic agent for age-related macular degeneration
03/17/2010EP2163543A1 Nitrogen-containing heterocyclic derivative having 11 beta-hydroxysteroid dehydrogenase type i inhibitory activity
03/17/2010EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
03/17/2010EP2163248A1 Benzothiazepine derivatives as ryanodine receptor (RYR2) inhibitors and their use in the treatment of cardiac diseases
03/17/2010EP2163243A1 Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
03/17/2010EP2162453A1 Crystalline form b of olmesartan medoxomil
03/17/2010EP2162442A1 Dual-acting benzoimidazole antihypertensive agents
03/17/2010EP2162438A2 Process for the preparation of ivabradine hydrochloride and polymorph thereof
03/17/2010EP2162434A2 Salts of perindopril
03/17/2010EP2026769B1 Bilayer tablet for preventing cardiovascular events
03/17/2010EP1708711B1 Compositions useful especially for treatment or prevention of metabolic syndrome
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010EP1250166B1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
03/17/2010CN101675059A Macrocyclic compound
03/17/2010CN101675048A 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
03/17/2010CN101675036A dual-acting benzoimidazole antihypertensive agents
03/17/2010CN101671723A Haplotype consisting of single nucleotide polymorphism of kynureninase gene
03/17/2010CN101671396A Vascular endothelial growth factor specifically combined with collagen and application thereof
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671389A Erythrocyte generating characteristic-free erythropoietin with nervous protecting function and application thereof
03/17/2010CN101671388A Blood brain barrier penetrable erythropoietin (EPO) and application thereof
03/17/2010CN101671294A Method for continuously extracting and separating 1-deoxynojirimycin (DNJ) and flavone from folium mori
03/17/2010CN101670106A Natural activator of soluble guanylate cyclase
03/17/2010CN101670099A Application of kynurenine aminotransferase in preparing medicament for treating hypertension
03/17/2010CN101670097A Application of cartilage oligomeric matrix protein in preparing medicine for treating vascular-calcification
03/17/2010CN101670095A Pharmaceutical composition for treating embolism and preparation method thereof
03/17/2010CN101670081A Medicament for treating arrhythmia
03/17/2010CN101670070A Traditional Chinese medicine composition for treating hypertension
03/17/2010CN101670041A Method for controlling quality of astragalus in Chinese medicine preparation
03/17/2010CN101670018A Method for preparing camellia saponin controlled-release tablets
03/17/2010CN101669995A Composite for treatment and health care of heart cerebrovascular diseases and preparation method thereof
03/17/2010CN101669981A Method for extracting hydroxyl naphthoquinone total pigment with supercritical carbon dioxide
03/17/2010CN101669980A Method for extracting and separating icariin and flavone from epimedium herb
03/17/2010CN101669978A Buffer-contained Chinese traditional medicine panax notoginseng saponins
03/17/2010CN101669977A Quality detection method of dogbane leaf capsule
03/17/2010CN101669971A Compound extracted from shark cartilage marrows
03/17/2010CN101669970A Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans
03/17/2010CN101669957A Pharmaceutical composition of lercanidpine and benazepril and application thereof
03/17/2010CN101669948A Sustained release tablets of nicotinic acid and lovatatin and preparation method thereof
03/17/2010CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof
03/17/2010CN101669944A Nimodipine sustained release preparation and preparation method thereof
03/17/2010CN101669940A Candesartan cilexetil/hydrochlorothiazide capsule and preparation method thereof
03/17/2010CN101669936A Drug combination containing pratensein and application thereof in drugs
03/17/2010CN101669935A Drug combination containing prunetin and application thereof in drugs
03/17/2010CN101669930A Medicament capable of radically treating cardiovascular and cerebrovascular diseases and hypertensions
03/17/2010CN101669918A Aspirin double-releasing preparation and preparation method thereof
03/17/2010CN101669916A Method for preparing nifedipine freeze-dried powder injection
03/17/2010CN101669912A Slow-release composition containing tamsulosin and preparation thereof
03/17/2010CN101669904A Epoprostanol lipid nanoparticle and preparation method thereof
03/17/2010CN100594026C Pharmaceutical use of smallflower thinleaf crazyweed total alkaloid and azahexacyclonone derivative
03/17/2010CN100594025C Drop pills of hippophase rhamnoides and preparation method
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678921 Method for the enantiomoeric separation of optical active amlodipine
03/16/2010US7678916 crystalline rosiglitazone maleate filtration
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010CA2526586C The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2459981C For producing biologically active products
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2436724C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/16/2010CA2302838C Modulation of the sphingosine kinase signalling pathway
03/16/2010CA2191577C Method for treating and preventing atherosclerosis
03/11/2010WO2010028190A2 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 1595